# Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

> **NCT06760039** · PHASE1,PHASE2 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 112 (estimated)

## Conditions studied

- Diffuse Large B-Cell Lymphoma

## Interventions

- **DRUG:** R-CMOP Regimen
- **DRUG:** R-CHOP Regimen

## Key facts

- **NCT ID:** NCT06760039
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-10
- **Primary completion:** 2028-08-31
- **Final completion:** 2028-11-30
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06760039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06760039, "Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT06760039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*